16 Jan 2025 BioSPX Announces New Collaboration with Amphasys for Enhanced Bioprocessing Solutions Member news
15 Jan 2025 First in Belgium: Gevers and CAPE IP Law become a full-service partner in intellectual property Member news
15 Jan 2025 ONTOFORCE and Rancho Biosciences Collaborate to Leverage High-Quality Data for Target Identification Member news
13 Jan 2025 KU Leuven and SandboxAQ Partner to Accelerate the Search for Parkinson’s Treatments with AI Member news
08 Jan 2025 Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities Member news
07 Jan 2025 Six Month Data from alfapump® Pivotal POSEIDON Study in Treatment of Recurrent or Refractory Ascites due to Liver Cirrhosis Published in American Journal of Gastroenterology Member news
07 Jan 2025 Research reveals unique features of brain cells linked to neurodevelopmental conditions Member news
30 Dec 2024 Precigen ActoBio Announces Additional Positive Interim Data from Phase 1b/2a Study of AG019 ActoBiotics™, A Novel Therapy Designed to Address the Underlying Cause of Type 1 Diabetes Member news
23 Dec 2024 Sequana Medical Announces US FDA Approval of alfapump® for the Treatment of Recurrent or Refractory Ascites due to Liver Cirrhosis Member news
More info? Ellen Telleir Communication Coordinator linkedin.com/in/ellentelleir/ +32 9 241 80 41 ellen.telleir@flanders.bio Contact us
